RxDoctor Payments Data

Belinda Gavino, MD

Family Medicine · Sebring, FLNPI 1750711636

Payments from drug & device makers

$591in general payments, 2019–2025

Across 22 payments — averaging $26.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$169
  • AstraZeneca$119
  • Dexcom, Inc.$90
  • Lilly USA, LLC$66
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$46
  • GSK$36
  • plus $66 from 4 others

What the payments were for

  • Food & beverage$591100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$591 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$71,537
Medicare patients
246
Services billed
830

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide98$100,685
MounjaroTirzepatide65$83,671
Enbrel SureclickEtanercept11$76,980
EliquisApixaban58$50,921
EntrestoSacubitril/Valsartan29$44,722
JardianceEmpagliflozin34$33,688
TrulicityDulaglutide26$29,722
FarxigaDapagliflozin Propanediol20$21,877
XareltoRivaroxaban13$20,906
JanuviaSitagliptin Phosphate24$20,673
RybelsusSemaglutide11$17,708
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$13,506
Tresiba Flextouch U-100Insulin Degludec21$10,340
Atrovent HfaIpratropium Bromide13$5,744
Breo ElliptaFluticasone/Vilanterol11$5,715

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$169$118,393109 claims
Lilly USA, LLCMounjaro, Trulicity, Humulin 70-30$66$115,161116 claims
Boehringer IngelheimJardiance$15$33,68834 claims
AstraZenecaFarxiga$119$21,87720 claims
GSKTrelegy Ellipta, Breo Ellipta$36$19,22125 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Sebring

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →